Atrial fibrillation (AFib) is a common cardiac arrhythmia and increases the risk of suffering a stroke. According to the current ESC guideline, patients with VHF without a clear contraindication should not be withheld oral anticoagulation. The CHA2DS2-VASc score can be used to estimate the risk of stroke. The HAS-BLED score has proven useful for risk stratification with regard to bleeding complications. Several recent randomized studies have investigated the situation in patients with device-detected atrial fibrillation.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
- CARDIOVASC
Related Topics
You May Also Like
- Podiatry support to improve quality of life
Patient mobility with a foot wound
- Rare diseases
Cogan syndrome – a clinical challenge
- Polymyalgia rheumatica and giant cell arteritis
New consensus paper recommends “treat-to-target” strategy
- Systemic lupus erythematosus
DORIS and LLDAS are also worthwhile for severe cases
- Malnutrition in old age
A problem underestimated for a long time
- Practice Management
Burnout prevention in the practice team – basics and strategies
- Stroke
With polypills and co. against stroke and its consequences
- Post-COVID